Inhibition of SGK1 enhances mAR-induced apoptosis in MCF-7 breast cancer cells

References

• Kampa M, Papakonstanti EA, Hatzoglou A, Stathopoulos EN, Stournaras C, Castanas E. The human prostate cancer cell line LNCaP bears functional membrane testosterone receptors that increase PSA secretion and modify actin cytoskeleton. FASEB J 2002; 16:1429-31; PMID:12205037
   PubMed Web of Science ®Google Scholar
• Papadopoulou N, Charalampopoulos I, Alevizopoulos K, Gravanis A, Stournaras C. Rho/ROCK/actin signaling regulates membrane androgen receptor induced apoptosis in prostate cancer cells. Exp Cell Res 2008; 314:3162-74; PMID:18694745; http://dx.doi.org/10.1016/j.yexcr.2008.07.012
   PubMed Web of Science ®Google Scholar
• Papakonstanti EA, Kampa M, Castanas E, Stournaras C. A rapid, nongenomic, signaling pathway regulates the actin reorganization induced by activation of membrane testosterone receptors. Mol Endocrinol 2003; 17:870-81; PMID:12554777; http://dx.doi.org/10.1210/me.2002-0253
   PubMed Web of Science ®Google Scholar
• Sen A, O’Malley K, Wang Z, Raj GV, Defranco DB, Hammes SR. Paxillin regulates androgen- and epidermal growth factor-induced MAPK signaling and cell proliferation in prostate cancer cells. J Biol Chem 2010; 285:28787-95; PMID:20628053; http://dx.doi.org/10.1074/jbc.M110.134064
   PubMed Web of Science ®Google Scholar
• Sun YH, Gao X, Tang YJ, Xu CL, Wang LH. Androgens induce increases in intracellular calcium via a G protein-coupled receptor in LNCaP prostate cancer cells. J Androl 2006; 27:671-8; PMID:16728719; http://dx.doi.org/10.2164/jandrol.106.000554
   PubMed Web of Science ®Google Scholar
• Kampa M, Kogia C, Theodoropoulos PA, Anezinis P, Charalampopoulos I, Papakonstanti EA, Stathopoulos EN, Hatzoglou A, Stournaras C, Gravanis A, et al. Activation of membrane androgen receptors potentiates the antiproliferative effects of paclitaxel on human prostate cancer cells. Mol Cancer Ther 2006; 5:1342-51; PMID:16731768; http://dx.doi.org/10.1158/1535-7163.MCT-05-0527
   PubMed Web of Science ®Google Scholar
• Kampa M, Nifli AP, Charalampopoulos I, Alexaki VI, Theodoropoulos PA, Stathopoulos EN, Gravanis A, Castanas E. Opposing effects of estradiol- and testosterone-membrane binding sites on T47D breast cancer cell apoptosis. Exp Cell Res 2005; 307:41-51; PMID:15922725; http://dx.doi.org/10.1016/j.yexcr.2005.02.027
   PubMed Web of Science ®Google Scholar
• Kallergi G, Agelaki S, Markomanolaki H, Georgoulias V, Stournaras C. Activation of FAK/PI3K/Rac1 signaling controls actin reorganization and inhibits cell motility in human cancer cells. Cell Physiol Biochem 2007; 20:977-86; PMID:17982280; http://dx.doi.org/10.1159/000110458
   PubMed Web of Science ®Google Scholar
• Gu S, Papadopoulou N, Gehring EM, Nasir O, Dimas K, Bhavsar SK, Föller M, Alevizopoulos K, Lang F, Stournaras C. Functional membrane androgen receptors in colon tumors trigger pro-apoptotic responses in vitro and reduce drastically tumor incidence in vivo. Mol Cancer 2009; 8:114; PMID:19948074; http://dx.doi.org/10.1186/1476-4598-8-114
   PubMed Web of Science ®Google Scholar
• Gu S, Papadopoulou N, Nasir O, Foller M, Alevizopoulos K, Lang F, Stournaras C. Activation of membrane androgen receptors in colon cancer inhibits the prosurvival signals Akt/bad in vitro and in vivo and blocks migration via vinculin/actin signaling. Mol Med 2011; 17:48-58; PMID:20957335; http://dx.doi.org/10.2119/molmed.2010.00120
   PubMed Web of Science ®Google Scholar
• Gatson JW, Kaur P, Singh M. Dihydrotestosterone differentially modulates the mitogen-activated protein kinase and the phosphoinositide 3-kinase/Akt pathways through the nuclear and novel membrane androgen receptor in C6 cells. Endocrinology 2006; 147:2028-34; PMID:16410299; http://dx.doi.org/10.1210/en.2005-1395
   PubMed Web of Science ®Google Scholar
• Lang F, Alevizopoulos K, Stournaras C. Targeting membrane androgen receptors in tumors. Expert Opin Ther Targets 2013; 17:951-63; PMID:23746222; http://dx.doi.org/10.1517/14728222.2013.806491
   PubMed Web of Science ®Google Scholar
• Papadopoulou N, Papakonstanti EA, Kallergi G, Alevizopoulos K, Stournaras C. Membrane androgen receptor activation in prostate and breast tumor cells: molecular signaling and clinical impact. IUBMB Life 2009; 61:56-61; PMID:19109827; http://dx.doi.org/10.1002/iub.150
   PubMed Web of Science ®Google Scholar
• Papadopoulou N, Charalampopoulos I, Anagnostopoulou V, Konstantinidis G, Foller M, Gravanis A, Alevizopoulos K, Lang F, Stournaras C. Membrane androgen receptor activation triggers down-regulation of PI-3K/Akt/NF-kappaB activity and induces apoptotic responses via Bad, FasL and caspase-3 in DU145 prostate cancer cells. Molecular cancer 2008; 7:88; PMID:19055752; http://dx.doi.org/10.1186/1476-4598-7-88
   PubMed Web of Science ®Google Scholar
• Hatzoglou A, Kampa M, Kogia C, Charalampopoulos I, Theodoropoulos PA, Anezinis P, Dambaki C, Papakonstanti EA, Stathopoulos EN, Stournaras C, et al. Membrane androgen receptor activation induces apoptotic regression of human prostate cancer cells in vitro and in vivo. J Clin Endocrinol Metab 2005; 90:893-903; PMID:15585562; http://dx.doi.org/10.1210/jc.2004-0801
   PubMed Web of Science ®Google Scholar
• Lang F, Perrotti N, Stournaras C. Colorectal carcinoma cells-regulation of survival and growth by SGK1. Int J Biochem Cell Biol 2010; 42:1571-5; PMID:20541034; http://dx.doi.org/10.1016/j.biocel.2010.05.016
   PubMed Web of Science ®Google Scholar
• Lang F, Stournaras C. Serum and glucocorticoid inducible kinase, metabolic syndrome, inflammation, and tumor growth. Hormones 2013; 12:160-71; PMID:23933686; http://dx.doi.org/10.14310/horm.2002.1401
   PubMedGoogle Scholar
• Shanmugam I, Cheng G, Terranova PF, Thrasher JB, Thomas CP, Li B. Serum/glucocorticoid-induced protein kinase-1 facilitates androgen receptor-dependent cell survival. Cell Death Differ 2007; 14:2085-94; PMID:17932503; http://dx.doi.org/10.1038/sj.cdd.4402227
   PubMed Web of Science ®Google Scholar
• Zou JX, Guo L, Revenko AS, Tepper CG, Gemo AT, Kung HJ, Chen HW. Androgen-induced coactivator ANCCA mediates specific androgen receptor signaling in prostate cancer. Cancer Res 2009; 69:3339-46; PMID:19318566; http://dx.doi.org/10.1158/0008-5472.CAN-08-3440
   PubMed Web of Science ®Google Scholar
• Schmidt EM, Gu S, Anagnostopoulou V, Alevizopoulos K, Foller M, Lang F, Stournaras C. Serum- and glucocorticoid-dependent kinase-1-induced cell migration is dependent on vinculin and regulated by the membrane androgen receptor. FEBS J 2012; 279:1231-42; PMID:22309306; http://dx.doi.org/10.1111/j.1742-4658.2012.08515.x
   PubMed Web of Science ®Google Scholar
• Ackermann TF, Boini KM, Beier N, Scholz W, Fuchss T, Lang F. EMD638683, a novel SGK inhibitor with antihypertensive potency. Cell Physiol Biochem 2011; 28:137-46; PMID:21865856; http://dx.doi.org/10.1159/000331722
   PubMed Web of Science ®Google Scholar
• Lu Q, Rounds S. Focal adhesion kinase and endothelial cell apoptosis. Microvasc Res 2012; 83:56-63; PMID:21624380; http://dx.doi.org/10.1016/j.mvr.2011.05.003
   PubMed Web of Science ®Google Scholar
• Hanks SK, Ryzhova L, Shin NY, Brabek J. Focal adhesion kinase signaling activities and their implications in the control of cell survival and motility. Front Biosci 2003; 8:d982-96; PMID:12700132; http://dx.doi.org/10.2741/1114
   PubMed Web of Science ®Google Scholar
• Lang F, Voelkl J. Therapeutic potential of serum and glucocorticoid inducible kinase inhibition. Expert Opin Investig Drugs 2013; 22:701-14; PMID:23506284; http://dx.doi.org/10.1517/13543784.2013.778971
   PubMed Web of Science ®Google Scholar
• Nasir O, Wang K, Foller M, Gu S, Bhandaru M, Ackermann TF, Boini KM, Mack A, Klingel K, Amato R, et al. Relative resistance of SGK1 knockout mice against chemical carcinogenesis. IUBMB Life 2009; 61:768-76; PMID:19548318; http://dx.doi.org/10.1002/iub.209
   PubMed Web of Science ®Google Scholar
• Schmidt EM, Kraemer BF, Borst O, Munzer P, Schonberger T, Schmidt C, Leibrock C, Towhid ST, Seizer P, Kuhl D, et al. SGK1 sensitivity of platelet migration. Cell Physiol Biochem 2012; 30:259-68; PMID:22759972; http://dx.doi.org/10.1159/000339062
   PubMed Web of Science ®Google Scholar
• Schmid E, Gu S, Yang W, Munzer P, Schaller M, Lang F, Stournaras C, Shumilina E. Serum- and glucocorticoid-inducible kinase SGK1 regulates reorganization of actin cytoskeleton in mast cells upon degranulation. Am J Physiol Cell Physiol 2013; 304:C49-55; PMID:23015548; http://dx.doi.org/10.1152/ajpcell.00179.2012
   PubMedGoogle Scholar
• Towhid ST, Liu GL, Ackermann TF, Beier N, Scholz W, Fuchss T, Toulany M, Rodemann HP, Lang F. Inhibition of colonic tumor growth by the selective SGK inhibitor EMD638683. Cell Physiol Biochem 2013; 32:838-48; PMID:24081014; http://dx.doi.org/10.1159/000354486
   PubMed Web of Science ®Google Scholar
• Toulany M, Kehlbach R, Florczak U, Sak A, Wang S, Chen J, Lobrich M, Rodemann HP. Targeting of AKT1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repair. Mol Cancer Ther 2008; 7:1772-81; PMID:18644989; http://dx.doi.org/10.1158/1535-7163.MCT-07-2200
   PubMed Web of Science ®Google Scholar
• Brown JM, Wouters BG. Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res 1999; 59:1391-9; PMID:10197600
   PubMed Web of Science ®Google Scholar
• Kasten-Pisula U, Windhorst S, Dahm-Daphi J, Mayr G, Dikomey E. Radiosensitization of tumour cell lines by the polyphenol Gossypol results from depressed double-strand break repair and not from enhanced apoptosis. Radiother Oncol 2007; 83:296-303; PMID:17521756; http://dx.doi.org/10.1016/j.radonc.2007.04.024
   PubMed Web of Science ®Google Scholar
• Franklin-Tong VE, Gourlay CW. A role for actin in regulating apoptosis/programmed cell death: evidence spanning yeast, plants and animals. Biochem J 2008; 413:389-404; PMID:18613816; http://dx.doi.org/10.1042/BJ20080320
   PubMed Web of Science ®Google Scholar
• Gourlay CW, Ayscough KR. The actin cytoskeleton: a key regulator of apoptosis and ageing? Nat Rev Mol Cell Biol 2005; 6:583-9; PMID:16072039; http://dx.doi.org/10.1038/nrm1682
   PubMed Web of Science ®Google Scholar
• Papakonstanti EA, Stournaras C. Tumor necrosis factor-alpha promotes survival of opossum kidney cells via Cdc42-induced phospholipase C-gamma1 activation and actin filament redistribution. Mol Biol Cell 2004; 15:1273-86; PMID:14699068; http://dx.doi.org/10.1091/mbc.E03-07-0491
   PubMed Web of Science ®Google Scholar
• Wang Y, George SP, Srinivasan K, Patnaik S, Khurana S. Actin reorganization as the molecular basis for the regulation of apoptosis in gastrointestinal epithelial cells. Cell Death Differ 2012; 19:1514-24; PMID:22421965; http://dx.doi.org/10.1038/cdd.2012.28
   PubMed Web of Science ®Google Scholar
• Kramar EA, Chen LY, Brandon NJ, Rex CS, Liu F, Gall CM, Lynch G. Cytoskeletal changes underlie estrogen's acute effects on synaptic transmission and plasticity. J Neurosci 2009; 29:12982-93; PMID:19828812; http://dx.doi.org/10.1523/JNEUROSCI.3059-09.2009
   PubMed Web of Science ®Google Scholar
• Olson EN, Nordheim A. Linking actin dynamics and gene transcription to drive cellular motile functions. Nat Rev Mol Cell Biol 2010; 11:353-65; PMID:20414257; http://dx.doi.org/10.1038/nrm2890
   PubMed Web of Science ®Google Scholar
• Stournaras C, Gravanis A, Margioris AN, Lang F. The actin cytoskeleton in rapid steroid hormone actions. Cytoskeleton 2014; 71:285-93; PMID:24616288; http://dx.doi.org/10.1002/cm.21172
   PubMed Web of Science ®Google Scholar
• Zaru R, Mollahan P, Watts C. 3-phosphoinositide-dependent kinase 1 deficiency perturbs Toll-like receptor signaling events and actin cytoskeleton dynamics in dendritic cells. J Biol Chem 2008; 283:929-39; PMID:17991746; http://dx.doi.org/10.1074/jbc.M708069200
   PubMed Web of Science ®Google Scholar
• Gu S, Kounenidakis M, Schmidt EM, Deshpande D, Alkahtani S, Alarifi S, Föller M, Alevizopoulos K, Lang F, Stournaras C. Rapid activation of FAK/mTOR/p70S6K/PAK1-signaling controls the early testosterone-induced actin reorganization in colon cancer cells. Cell Signal 2013; 25:66-73; PMID:23316499; http://dx.doi.org/10.1016/j.cellsig.2012.08.005
   PubMed Web of Science ®Google Scholar
• Papakonstanti EA, Stournaras C. Actin cytoskeleton architecture and signaling in osmosensing. Methods Enzymol 2007; 428:227-40; PMID:17875420; http://dx.doi.org/10.1016/S0076-6879(07)28012-7
   PubMed Web of Science ®Google Scholar